Champions Oncology | Sustainability Performance
Develops oncology drug discovery and personalized cancer treatment solutions.
2007
United States
51 - 200 employees
Biotechnology
$25M - 100M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#4617
Overall#991
in United States#57
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Digital emissionsGovernance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
Green HostingNo
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$56.0MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
10.7%FY2025
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
118.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.1
▼ 1.5%
0.1
▲ 2.4%
0.1
▼ 1.1%
0.1
2031Powered by illuminem
Sustainability targets and commitments
| Target | Year | Value | Scope | Baseline |
|---|
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
63%
Independent Directors
5 out of 8 incl. management
Overall score
36
Environment
40
Social
32
Governance
36
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
